Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia (AML)

More than 500 clinical trials are currently accepting participants diagnosed with Acute Myeloid Leukaemia (AML).

Acute Myeloid Leukaemia (AML) is a type of blood cancer originating in the bone marrow. It begins in young white blood cells, specifically granulocytes or monocytes. The bone marrow, where AML develops, is the soft, inner part of the bones responsible for new blood cell formation.

What clinical trials are

Learn more

Before you take part in a clinical trial

Learn more

Find the right clinical trial

Learn more